Clinical Trial Update: EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Edoxaban vs Warfarin in device procedures for non-valvular atrial fibrillation was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Electrophysiology Research Foundation | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2020-02-10